Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?

Pharmacogenomics
Jenny E HiggsWilliam G Newman

Abstract

Thiopurine S-methyltransferase (TPMT) metabolizes thiopurine medications, including azathioprine and 6-mercaptopurine. Absent TPMT activity (i.e., in individuals homozygous for a variant TPMT allele) is associated with an increased risk of myelosuppression in patients taking thiopurine drugs. However, it is not clear if there is also an increased risk for patients with intermediate TPMT activity (i.e., in individuals heterozygous for a variant TPMT allele). To quantify the increased risk of myelosuppression for patients with intermediate TPMT activity. A systematic review identified published studies, up to 29 September 2008, that explored the relationship between TMPT and hematological adverse drug reactions to thiopurines. Following a critical appraisal of the quality of published studies, a meta-analysis calculated the odds ratio of myelosuppression for patients with intermediate TPMT activity compared with wild-type. A total of 67 studies were identified, the majority retrospective cohort in design. Patients with two TPMT variant alleles who are TPMT deficient have a substantial increase in their risk of myelotoxicity (86% of deficient patients developed myelosuppression). The increase in odds ratio of developing leukopenia...Continue Reading

References

May 2, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·R M WeinshilboumP A Pazmiño
Aug 1, 1989·Clinical Pharmacology and Therapeutics·L LennardR M Weinshilboum
Mar 1, 1997·The British Journal of Dermatology·B B TanJ S English
Dec 2, 1999·Journal of the National Cancer Institute·M V RellingW E Evans
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W E EvansM V Relling
Jul 4, 2002·QJM : Monthly Journal of the Association of Physicians·S A HolmeA V Anstey
Sep 25, 2002·Alimentary Pharmacology & Therapeutics·A AnsariJ Sanderson
Sep 28, 2002·Journal of Pediatric Gastroenterology and Nutrition·Carolina RumboBenjamin L Shneider
Mar 8, 2003·Alimentary Pharmacology & Therapeutics·K R HerrlingerE F Stange
Sep 25, 2003·Journal of Gastroenterology·Toshifumi HibiTakashi Shimoyama
Feb 13, 2004·Gut·A Cardenas, C Kelly
Apr 30, 2004·Statistics in Medicine·Michael J SweetingPaul C Lambert
May 29, 2004·Therapeutic Drug Monitoring·Luc J J DerijksPiet M Hooymans
Aug 13, 2004·Gut·M J CarterUNKNOWN IBD Section, British Society of Gastroenterology
Oct 13, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Christine M FormeaJanet L Karlix
Nov 17, 2004·Scandinavian Journal of Gastroenterology·U HindorfK Schmiegelow
Feb 16, 2005·Alimentary Pharmacology & Therapeutics·F N Aberra, G R Lichtenstein
Mar 19, 2005·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Farzana A SayaniRichard N Fedorak
Jun 24, 2005·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·David P BreenPeter C Hayes

❮ Previous
Next ❯

Citations

Oct 26, 2010·Pharmacy World & Science : PWS·Chaker Ben SalemKamel Bouraoui
Sep 7, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Josh F PetersonJosh C Denny
Aug 10, 2011·Nature Reviews. Rheumatology·Lesley Davila, Prabha Ranganathan
Jul 2, 2010·World Journal of Gastroenterology : WJG·Xian-Wen DongZhi-Hua Ran
Nov 1, 2012·Indian Journal of Pharmacology·Baisakhi LahaAvijit Hazra
May 9, 2013·Pharmacogenomics·Brian MurrayMary W Roederer
Sep 21, 2012·Expert Review of Clinical Immunology·Ibrahim IbrahimAnne Barton
Dec 28, 2010·Trends in Pharmacological Sciences·Sarah C Sim, Magnus Ingelman-Sundberg
Dec 23, 2014·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·E A HullahJ D Sanderson
Mar 7, 2014·British Journal of Clinical Pharmacology·Anastasia KonidariWael El-Matary
Aug 22, 2013·British Journal of Clinical Pharmacology·Lynne Lennard
Nov 26, 2013·Journal of Neurology·Corinna TrebstUNKNOWN Neuromyelitis Optica Study Group (NEMOS)
Sep 13, 2016·International Journal of Molecular Sciences·Vid MlakarMarc Ansari
Sep 18, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Grace Juyun KimJu Han Kim
Sep 20, 2016·The Journal of Pediatrics·Alison L T MaStephen D Marks
Feb 4, 2016·Expert Review of Neurotherapeutics·Joanna Kitley, Jackie Palace
Jan 6, 2012·Arquivos de neuro-psiquiatria·Douglas SatoUNKNOWN Brazilian Committee for Treatment and Research in Multiple Sclerosis
Jul 7, 2012·Arquivos De Gastroenterologia·Gabriela Roncone GastalMauro Pinho
Nov 20, 2016·Journal of Gastroenterology and Hepatology·Berrie MeijerNanne K H de Boer
Jul 6, 2017·Expert Review of Clinical Immunology·Robin J Dart, Peter M Irving
Jan 15, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eugenia VispoUNKNOWN European Network of Clinical Trials (NEAT)
Nov 22, 2016·World Journal of Gastrointestinal Pharmacology and Therapeutics·Berrie MeijerNanne K H de Boer
May 9, 2015·Therapeutic Advances in Chronic Disease·Rishi M GoelJeremy D Sanderson
Nov 26, 2013·British Journal of Hospital Medicine·K L de WitD Goldsmith
May 21, 2014·The American Journal of Gastroenterology·Mahmoud H MosliBrian G Feagan
Jan 31, 2019·Journal of Crohn's & Colitis·Reinier L SluiterMarieke J H Coenen
Dec 16, 2010·Current Opinion in Infectious Diseases·Eugenia VispoVincent Soriano
Jul 26, 2019·Alimentary Pharmacology & Therapeutics·Sara van GennepNanne K H de Boer
Nov 5, 2019·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Anthony M Marinaki, Monica Arenas-Hernandez
Sep 1, 2017·European Journal of Gastroenterology & Hepatology·Constantina CoucoutsiElias A Kouroumalis
Aug 28, 2020·Pharmacogenomics and Personalized Medicine·Dimitri MaamariNathalie K Zgheib

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.